
|Articles|January 1, 2007
Statins, fibrates won't help
New York - Cholesterol-lowering statins and fibrates apparently aren't linked to a reduced risk of melanoma, researchers report.
Advertisement
New York - Cholesterol-lowering statins and fibrates apparently aren't linked to a reduced risk of melanoma, researchers report.
Investigators came to the conclusion after reviewing data from 20 randomized controlled trials involving almost 71,000 participants, according to the Nov. 1 issue of the Journal of the National Cancer Institute.
Twelve trials were for statins and eight for fibrates, Reuters reports.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
5


















